October 8, 2018 @ 7:35 pm | Breaking News, Jubak Picks Portfolio, NKTR, Update, Volatility |
The longs and the shorts continue to battle over Nektar Therapeutics (NKTR.) Right now the shorts have the best of that fight. No contest. The shares of this biotech fell another 1.24% today to close at $51.71. A little more than a month ago they were at $68.49. But I...
August 29, 2018 @ 6:58 pm | Breaking News, Jubak Picks Portfolio, NKTR, Update |
I wrote this post while on vacation in an effort to use this down time to catch up on earnings results that I missed during the very busy second quarter earning season. This post was written on August 18. After the market close on Wednesday, August 8,...
April 30, 2018 @ 7:03 pm | Breaking News, Jubak Picks Portfolio, NKTR, Update, Volatility |
Shares of biotech rocket Nektar Therapeutics (NKTR) are down 23.25% since they traded at $106.91 on March 21, 2018. I can’t find evidence that the positive catalysts that led me to recommend the stock for my Jubak Picks portfolio and the options for my...
March 2, 2018 @ 6:38 pm | Breaking News, Jubak Picks Portfolio, NKTR |
Shares of Nektar Therapeutics (NKTR) finished up 21.67% today to $102.87 after the biotech company announced after the close yesterday a smaller than expected fourth quarter 2017 loss of 21 cents a share (versus the Wall Street consensus projection of a 36 cents a...
November 13, 2017 @ 7:36 pm | Breaking News, Buy, Jubak Picks Portfolio, NKTR, Volatility |
Nektar Therapeutics (NKTR) shares finished the day up 14.15% on fairly preliminary, but very important data from the trials of the company’s lead cancer drug. Those results go a long way to validating the company’s entire pipeline of drug candidates to...